Relapse outcomes, safety, and treatment patterns in patients diagnosed with relapsing-remitting multiple sclerosis and initiated on subcutaneous interferon β-1a or dimethyl fumarate: a real-world study-Reference-Cited by-同舟云学术

Relapse outcomes, safety, and treatment patterns in patients diagnosed with relapsing-remitting multiple sclerosis and initiated on subcutaneous interferon β-1a or dimethyl fumarate: a real-world study

Published:2017-09-28 Issue:12 Volume:33 Page:2099-2106
ISSN:0300-7995
Container-title:Current Medical Research and Opinion
language:en
Short-container-title:Current Medical Research and Opinion

Author:

Ernst Frank R.¹,Barr Peri¹,Elmor Riad¹,Wong Schiffon L.²

Affiliation:

1. Health Economics and Outcomes Research, Indegene, Inc., Kennesaw, GA, USA;

2. Global Evidence & Value Development, Global Research & Development, EMD Serono, Inc., Billerica, MA, USA

Publisher

Informa UK Limited

Subject

General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/03007995.2017.1380616

Reference32 articles.

1. Multiple Sclerosis Coalition. The use of disease-modifying therapies in multiple sclerosis: principles and current evidence. MSC; 2016. Available at: http://ms-coalition.org/cms/images/stories//dmt_consensus_ms_coalition092016.pdf. May 12, 2017

2. Narrative Review of the Literature on Adherence to Disease-Modifying Therapies Among Patients with Multiple Sclerosis

3. Identification and Prioritization of Important Attributes of Disease-Modifying Drugs in Decision Making among Patients with Multiple Sclerosis: A Nominal Group Technique and Best-Worst Scaling

4. Treatment Discontinuation and Disease Progression with Injectable Disease-Modifying Therapies

5. Persistency, medication prescribing patterns, and medical resource use associated with multiple sclerosis patients receiving oral disease-modifying therapies: a retrospective medical record review

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Twenty Years of Subcutaneous Interferon-Beta-1a for Multiple Sclerosis: Contemporary Perspectives;Neurology and Therapy;2024-01-11

2. The Efficacy of Fingolimod and Interferons in Controlling Disability and Relapse Rate in Patients with Multiple Sclerosis: A Systematic Review and Meta-Analysis;International Journal of Preventive Medicine;2023-12

3. Discontinuation of dimethyl fumarate in multiple sclerosis - a nationwide study;Multiple Sclerosis and Related Disorders;2023-12

4. Handling related publications reporting real-world evidence in network meta-analysis: a case study in multiple sclerosis;Journal of Comparative Effectiveness Research;2023-08

5. Effectiveness of Dimethyl Fumarate in Real-World Clinical Practice and Strategy to Minimize Adverse Effects and Use of Healthcare Resources;Patient Preference and Adherence;2021-01